BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33518631)

  • 1. Expression of P-glycoprotein and breast cancer resistance protein in three cases of canine lymphoma showing drug resistance.
    Hyokai S; Tanaka H; Aihara N; Kamiie J
    J Vet Med Sci; 2021 Apr; 83(3):473-477. PubMed ID: 33518631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Expression of Multidrug-Resistance (MDR) Transporters in Developing Human Fetal Brain Endothelial Cells.
    Lye P; Bloise E; Imperio GE; Chitayat D; Matthews SG
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells.
    Sakata S; Fujiwara M; Ohtsuka K; Kamma H; Nagane M; Sakamoto A; Fujioka Y
    Oncol Rep; 2011 Feb; 25(2):333-9. PubMed ID: 21165575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of P-glycoprotein and Breast Cancer Resistance Protein Expression Induced by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption: A Pilot Study.
    Conti A; Geffroy F; Kamimura HAS; Novell A; Tournier N; Mériaux S; Larrat B
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier.
    Li Y; Wu Q; Li C; Liu L; Du K; Shen J; Wu Y; Zhao X; Zhao M; Bao L; Gao J; Keep RF; Xiang J
    PLoS One; 2016; 11(6):e0157576. PubMed ID: 27300692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.
    Eisenblätter T; Hüwel S; Galla HJ
    Brain Res; 2003 May; 971(2):221-31. PubMed ID: 12706238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-Glycoprotein and Breast Cancer Resistance Protein in Canine Inflammatory and Noninflammatory Grade III Mammary Carcinomas.
    Levi M; Peña L; Alonso-Díez A; Brunetti B; Muscatello LV; Benazzi C; Pérez-Alenza MD; Sarli G
    Vet Pathol; 2019 Nov; 56(6):840-847. PubMed ID: 31526115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice.
    Agarwal S; Uchida Y; Mittapalli RK; Sane R; Terasaki T; Elmquist WF
    Drug Metab Dispos; 2012 Jun; 40(6):1164-9. PubMed ID: 22401960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease.
    Arduino I; Iacobazzi RM; Riganti C; Lopedota AA; Perrone MG; Lopalco A; Cutrignelli A; Cantore M; Laquintana V; Franco M; Colabufo NA; Luurtsema G; Contino M; Denora N
    Int J Pharm; 2020 Dec; 591():120011. PubMed ID: 33115695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta.
    Lye P; Bloise E; Nadeem L; Gibb W; Lye SJ; Matthews SG
    J Cell Mol Med; 2018 Jul; 22(7):3652-3660. PubMed ID: 29691980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and Validation of Canine P-Glycoprotein-Deficient MDCK II Cell Lines for Efflux Substrate Screening.
    Ye D; Harder A; Fang Z; Weinheimer M; Laplanche L; Mezler M
    Pharm Res; 2020 Sep; 37(10):194. PubMed ID: 32918191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Zn
    Zaremba A; Helm F; Fricker G
    Mol Pharm; 2019 Jan; 16(1):305-317. PubMed ID: 30422662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier.
    Liow JS; Zoghbi SS; Hu S; Hall MD; Hines CS; Shetty HU; Araneta MD; Page EM; Pike VW; Kreisl WC; Herscovitch P; Gottesman MM; Theodore WH; Innis RB
    Neuroimage; 2016 Sep; 138():134-140. PubMed ID: 27211474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combo-strategy to improve brain delivery of antiepileptic drugs: Focus on BCRP and intranasal administration.
    Gonçalves J; Silva S; Gouveia F; Bicker J; Falcão A; Alves G; Fortuna A
    Int J Pharm; 2021 Jan; 593():120161. PubMed ID: 33307160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.
    Han LW; Gao C; Mao Q
    Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):817-829. PubMed ID: 30010462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Human Brain Penetration of P-glycoprotein and Breast Cancer Resistance Protein Substrates Using In Vitro Transporter Studies and Animal Models.
    Feng B; Doran AC; Di L; West MA; Osgood SM; Mancuso JY; Shaffer CL; Tremaine L; Liras J
    J Pharm Sci; 2018 Aug; 107(8):2225-2235. PubMed ID: 29608887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells.
    Saeed MEM; Boulos JC; Elhaboub G; Rigano D; Saab A; Loizzo MR; Hassan LEA; Sugimoto Y; Piacente S; Tundis R; Yagi S; Khalid H; Efferth T
    Phytomedicine; 2019 Sep; 62():152945. PubMed ID: 31132750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) localize in the microvessels forming the blood-tumor barrier in ependymomas.
    Ginguené C; Champier J; Maallem S; Strazielle N; Jouvet A; Fèvre-Montange M; Ghersi-Egea JF
    Brain Pathol; 2010 Sep; 20(5):926-35. PubMed ID: 20406235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
    Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
    Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
    Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
    Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.